PHARMACOKINETICS AND EXPOSURE-RESPONSE FOR REGN1979, A BISPECIFIC ANTI-CD20 X ANTI-CD3 ANTIBODY, IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA.

被引：0
|
作者：
Yang, F. [1 ]
Zhu, M. [1 ]
Toroghi, M. [1 ]
Putluri, D. [1 ]
Yan, H. [1 ]
Davis, J. [1 ]
DiCioccio, A. [1 ]
机构：
[1] Regeneron Pharmaceut, New York, NY USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
OV-002
引用
收藏
页码：S120 / S120
页数：1
相关论文
共 50 条
  • [1] Clinical Activity of REGN1979, a Bispecific Human, Anti-CD20 x Anti-CD3 Antibody, in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL)
    Bannerji, Rajat
    Allan, John N.
    Arnason, Jon E.
    Brown, Jennifer R.
    Advani, Ranjana H.
    Barnes, Jeffrey A.
    Ansell, Stephen M.
    O'Brien, Susan M.
    Chavez, Julio
    Duell, Johannes
    David, Kevin A.
    Martin, Peter
    Joyce, Robin M.
    Charnas, Robert
    Ambati, Srikanth R.
    Adriaens, Lieve
    Ufkin, Melanie
    Zhu, Min
    Li, Jingjin
    Gasparini, Peter
    Ibrahim, Anfal
    Jankovic, Vladimir
    Fiaschi, Nathalie
    Aina, Olulanu
    Zhang, Wen
    Deering, Raquel P.
    Hamon, Sara
    Thurston, Gavin
    Murphy, Andrew J.
    Weinreich, David M.
    Yancopoulos, George D.
    Lowy, Israel
    Sternberg, David
    Topp, Max S.
    BLOOD, 2019, 134
  • [2] A Phase 2 Study of REGN1979, an Anti-CD20 x Anti-CD3 Bispecific Antibody (Ab), in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL)
    Topp, Max S.
    Duell, Johannes
    Li, Jingjin
    Jankovic, Vladimir
    Lowy, Israel
    Sternberg, David
    Adriaens, Lieve
    Peterman, Mary
    Ambati, Srikanth R.
    Bannerji, Rajat
    BLOOD, 2019, 134
  • [3] Safety and Preliminary Clinical Activity of REGN1979, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with B-NHL Previously Treated with CD20-Directed Antibody Therapy
    Bannerji, Rajat
    Advani, Ranjana H.
    Brown, Jennifer R.
    Arnason, Jon E.
    Barnes, Jeffrey A.
    Allan, John N.
    Ansell, Stephen M.
    O'Brien, Susan M.
    Chavez, Julio C.
    Adriaens, Lieve
    Ufkin, Melanie
    Kostic, Ana
    Paccaly, Anne Josee
    Gao, Bo
    Lowy, Israel
    Sternberg, David
    Topp, Max S.
    BLOOD, 2017, 130
  • [4] Phase 1 Study of REGN1979, an Anti-CD20 x Anti-CD3 Bispecific Monoclonal Antibody, in Patients with CD20+B-Cell Malignancies Previously Treated with CD20-Directed Antibody Therapy
    Bannerji, Rajat
    Brown, Jennifer R.
    Advani, Ranjana H.
    Arnason, Jon
    O'Brien, Susan M.
    Allan, John N.
    Chavez, Julio C.
    Barnes, Jeffrey A.
    Joyce, Robin
    Ansell, Stephen
    Topp, Max S.
    Adriaens, Lieve
    Ufkin, Melanie
    Kostic, Ana
    Paccaly, Anne
    Gao, Bo
    Trail, Pamela A.
    Lowy, Israel
    Brownstein, Carrie
    BLOOD, 2016, 128 (22)
  • [5] A Phase 1 Study of Plamotamab, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma: Recommended Dose Safety/Efficacy Update and Escalation Exposure-Response Analysis
    Patel, Krish
    Riedell, Peter A.
    Tilly, Herve
    Ahmed, Sairah
    Michot, Jean-Marie
    Ghesquieres, Herve
    de Collela, Jean Marc Schiano
    Chanan-Khan, Asher
    Bouabdallah, Kamal
    Tessoulin, Benoit
    Iyengar, Sunil
    Long, Meixiao
    Clynes, Raphael
    Kanodia, Jitendra
    Bao, Lei
    Ding, Ying
    Jin, Jianhua
    Ainsworth, William B.
    Garcha, Raman
    Kye, Steve
    Phillips, Tycel J.
    BLOOD, 2022, 140 : 9470 - 9472
  • [6] TRANSLATIONAL FINDINGS FOR REGN1979, A HUMAN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY: FROM PRECLINICAL TO FIRST-IN-HUMAN STUDY IN PATIENTS WITH CD20+B-CELL MALIGNANCIES.
    Zhu, M.
    Smith, E.
    Kirshner, J.
    Toroghi, M.
    Davis, J.
    Di-Cioccio, A.
    Retter, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S103 - S103
  • [7] Safety and Preliminary Antitumor Activity of the Anti-PD-1 Monoclonal Antibody REGN2810 Alone or in Combination with REGN1979, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with B-Lymphoid Malignancies
    Topp, Max S.
    Borchmann, Peter
    Wagner-Johnston, Nina D.
    Provencio, Mariano
    Cordoba, Raul
    Papadopoulos, Kyriakos
    Martin, Alejandro
    Grande, Carlos
    Jagadeesh, Deepa
    Lakhani, Nehal
    de Vos, Sven
    Mato, Anthony R.
    Brunnberg, Uta
    Scholl, Sebastian
    Pott, Christiane
    Rutherford, Sarah C.
    Duell, Johannes
    Adriaens, Lieve
    Ufkin, Melanie
    Kostic, Ana
    Paccaly, Anne Josee
    Gao, Bo
    Lowy, Israel
    Sternberg, David
    Carpio, Cecilia
    BLOOD, 2017, 130
  • [8] Emerging Clinical Activity of REGN1979, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Follicular Lymphoma (FL), Diffuse Large B-Cell Lymphoma (DLBCL), and Other B-Cell Non-Hodgkin Lymphoma (B-NHL) Subtypes
    Bannerji, Rajat
    Arnason, Jon E.
    Advani, Ranjana
    Brown, Jennifer R.
    Allan, John N.
    Ansell, Stephen M.
    Barnes, Jeffrey
    O'Brien, Susan M.
    Chavez, Julio C.
    Duell, Johannes
    Lowy, Israel
    Charnas, Robert
    Sternberg, David
    Ambati, Srikanth
    Adriaens, Lieve
    Ufkin, Melanie
    Yan, Xiaoyu
    Li, Jingjin
    Navarro, Mark
    Gasparini, Peter
    Jankovic, Vladimir
    Fiaschi, Nathalie
    Zhang, Wen
    Hamon, Sara
    Thurston, Gavin
    Topp, Max S.
    BLOOD, 2018, 132
  • [9] Safety and Anti-Tumor Activity of Plamotamab (XmAb13676), an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Subjects with Relapsed/Refractory Non-Hodgkin's Lymphoma
    Patel, Krish
    Michot, Jean-Marie
    Chanan-Khan, Asher
    Ghesquieres, Herve
    Bouabdallah, Kamal
    Byrd, John C.
    Cartron, Guillaume
    Portell, Craig A.
    Solh, Melhem
    Tilly, Herve
    Wierda, William G.
    McGovern, Patricia
    Johnson, Chelsea
    Garcha, Raman
    Ribrag, Vincent
    Brisou, Gabriel
    Liebowitz, David
    Phillips, Tycel
    BLOOD, 2021, 138
  • [10] A Phase 2 Study of Odronextamab (REGN1979), a CD20 x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
    Kim, Tae Min
    Alonso, Arancha
    Prince, Miles
    Taszner, Michal
    Cho, Seok-Goo
    Stevens, Don A.
    Poon, Michelle
    Lim, Francesca
    Le Gouill, Steven
    Carpio, Cecilia
    Keating, Mary-Margaret
    Adriaens, Lieve
    Ufkin, Melanie
    Sabir, Ayesha
    Li, Jingjin
    Jankovic, Vladimir
    Zhu, Min
    Brouwer-Visser, Jurriaan
    Leng, Siyang
    Sirulnik, L. Andres
    Chaudhry, Aafia
    Ambati, Srikanth R.
    Seog, Kim Won
    BLOOD, 2020, 136
12345